EyePoint Pharmaceuticals
EYPT
$19.74
Share price
-1.00%
Change (1 day)
201.83%
Change (1 year)
Categories
EyePoint Pharmaceuticals (EYPT) - Net assets
Net assets on the balance sheet as of December 2023 : $0.26 B
According to EyePoint Pharmaceuticals
's latest financial reports the company has $0.26 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
EyePoint Pharmaceuticals - Net assets on balance sheet (from 2003 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.26 B | 176.36% |
| 2022-12-31 | $96.36 M | -47.73% |
| 2021-12-31 | $0.18 B | 894.44% |
| 2020-12-31 | $18.54 M | 122.58% |
| 2019-12-31 | $8.33 M | |
| 2018-06-30 | $11.68 M | -12.37% |
| 2017-06-30 | $13.33 M | -36.13% |
| 2016-06-30 | $20.88 M | -10.64% |
| 2015-06-30 | $23.36 M | 56.58% |
| 2014-06-30 | $14.92 M | 93.82% |
| 2013-06-30 | $7.7 M | -43.53% |
| 2012-06-30 | $13.63 M | -63.57% |
| 2011-06-30 | $37.43 M | 13.29% |
| 2010-06-30 | $33.04 M | 40.36% |
| 2009-06-30 | $23.54 M | -21.73% |
| 2008-06-30 | $30.07 M | -64% |
| 2007-06-30 | $83.54 M | -35.71% |
| 2006-06-30 | $0.12 B | 114.74% |
| 2005-06-30 | $60.52 M | 126.63% |
| 2004-06-30 | $26.7 M | 531.01% |
| 2003-06-30 | $4.23 M | |
| 2001-06-30 | $4.57 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$2.88 M | -101.08% | Bahamas |
 NRC Health
NRC | $48.95 M | -81.62% | 🇺🇸 USA |